Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about FORMA THERAPEUTICS HOLDINGS, INC.
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2500 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell Small Cap Comp..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000E Growth I..
CI
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
PU
06/14Forma Therapeutics Holdings, Inc. Announces Appointment of John Bishop as Chi..
CI
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
BU
06/11FORMA THERAPEUTICS : SVB Leerink Adjusts Forma Therapeutics Holdings PT to $54 F..
MT
06/11FORMA THERAPEUTICS : Presents New Phase 1 Data on Etavopivat (formerly referred ..
PU
06/11FORMA THERAPEUTICS : Presents New Phase 1 Data on Etavopivat (formerly referred ..
BU
06/11Forma Therapeutics Holdings, Inc. Presents New Phase 1 Data on Etavopivat At ..
CI
05/20FORMA THERAPEUTICS : to Present Data from Pivotal Phase 2 Trial of Olutasidenib ..
BU
05/20Forma Therapeutics Holdings, Inc. to Present Data from Pivotal Phase 2 Trial ..
CI
05/17FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
05/14FORMA THERAPEUTICS : Swings to Q1 Loss
MT
05/14Equities Poised for Stronger Session as US Futures Climb Pre-Bell; Europe, As..
MT
05/14Wall Street Leans Forward Pre-Bell; Futures Green, Europe Higher, Asia Up
MT
05/14FORMA THERAPEUTICS : Reports First Quarter 2021 Financial Results and Provides B..
BU
05/14Forma Therapeutics Holdings, Inc. Reports Unaudited Financial Results for the..
CI
05/06FORMA THERAPEUTICS : to Report First Quarter 2021 Financial Results and Provide ..
BU
03/31FORMA THERAPEUTICS : HC Wainwright Adjusts Forma Therapeutics Holdings' Price Ta..
MT
03/30FORMA THERAPEUTICS : Reports Narrower Q4 Loss
MT
03/30FORMA THERAPEUTICS : ' Sickle Cell Disease Drug Safe, Tolerable in Phase 1 Trial
MT
03/30FORMA THERAPEUTICS : Reports Fourth Quarter and Year-end 2020 Financial Results ..
BU
03/30Forma Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings R..
CI
03/30FORMA THERAPEUTICS : Announces Positive FT-4202 600 mg Multiple Ascending Dose C..
BU
03/30Forma Therapeutics Holdings, Inc. Announces Positive FT-4202 600 mg Multiple ..
CI
03/24Paolo Paoletti Notifies Forma Therapeutics Holdings, Inc. of His Intent to Re..
CI
03/23FORMA THERAPEUTICS : to Report Fourth Quarter and Year-end 2020 Financial Result..
BU
03/11Certain Common Stock of Forma Therapeutics Holdings, Inc. are subject to a Lo..
CI
03/11Certain Stock Option of Forma Therapeutics Holdings, Inc. are subject to a Lo..
CI
03/11Certain Equity Warrants of Forma Therapeutics Holdings, Inc. are subject to a..
CI
02/17FORMA THERAPEUTICS : Oppenheimer Initiates Coverage on Forma Therapeutics Holdin..
MT
02/17FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
01/20FORMA THERAPEUTICS : Starts Dosing in Early-Stage Clinical Trial of FT-7051 for ..
MT
01/20FORMA THERAPEUTICS : Announces First Patient Dosed in Phase 1 Clinical Trial Eva..
BU
01/20Forma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Ev..
CI
01/11FORMA THERAPEUTICS : Reviews 2020 Highlights and Outlines Key 2021 Milestones
BU
01/07FORMA THERAPEUTICS : Elects Renowned Doctor and Health Disparities Expert Selwyn..
BU
01/07Forma Therapeutics Holdings, Inc. Elects Selwyn M. Vickers, M.D., to Board of..
CI
2020FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) added to NASDAQ Biotechnology Index
CI
2020FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) added to S&P Biotechnology Select I..
CI
2020FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) added to S&P Global BMI Index
CI
2020Certain Stock Option of Forma Therapeutics Holdings, Inc. are subject to a Lo..
CI
2020Certain Common Stock of Forma Therapeutics Holdings, Inc. are subject to a Lo..
CI
2020Certain Series B-3 Convertible Preferred Stock of Forma Therapeutics Holdings..
CI
2020FORMA THERAPEUTICS : Raises $275.8 Million in Public Offering
MT
2020FORMA THERAPEUTICS : Announces Closing of Public Offering and Exercise in Full o..
BU
2020FORMA THERAPEUTICS : Prices $239.8 Million Public Offering
MT
2020FORMA THERAPEUTICS : Announces Pricing of Public Offering
BU
2020FORMA THERAPEUTICS : Launches Public Offering of 4.6 Million Shares
MT
2020FORMA THERAPEUTICS : Launches Proposed Public Offering
BU
2020SECTOR UPDATE : Health Care
MT
2020FORMA THERAPEUTICS : Rallies After Presenting Proof-of-Concept Data for Prospect..
MT
2020FORMA THERAPEUTICS : Cantor Fitzgerald Adjusts Price Target on Forma Therapeutic..
MT
2020FORMA THERAPEUTICS : Credit Suisse Adjusts Forma Therapeutics' Price Target to $..
MT
2020FORMA THERAPEUTICS : SVB Leerink Adjusts Forma Therapeutics' Price Target to $65..
MT
2020FORMA THERAPEUTICS : Presents Clinical Proof-of-Concept Data at the 62nd Annual ..
BU
2020Forma Therapeutics Holdings, Inc. Presents Clinical Proof-of-Concept Data at ..
CI
2020FORMA THERAPEUTICS : Cantor Fitzgerald Starts Forma Therapeutics at Overweight W..
MT
2020FORMA THERAPEUTICS : Reports Third Quarter 2020 Financial Results and Provides B..
AQ
2020FORMA THERAPEUTICS : Posts Narrower Q3 Net Loss
MT
2020FORMA THERAPEUTICS : Reports Third Quarter 2020 Financial Results and Provides B..
BU
2020Forma Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings R..
CI
2020FORMA THERAPEUTICS : Wins European Commission's Orphan Drug Designation for Sick..
MT
2020FORMA THERAPEUTICS : Announces FT-4202 Receives Orphan Drug Designation in Europ..
BU
2020FORMA THERAPEUTICS : Announces Four Oral and Poster Presentations on FT-4202 in ..
BU
2020FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
2020FORMA THERAPEUTICS : Announces Positive Top-line Olutasidenib Data from a Planne..
AQ
2020FORMA THERAPEUTICS : Announces Positive Top-line Olutasidenib Data From a Planne..
BU
2020Forma Therapeutics Announces Positive Top-line Olutasidenib Data From a Plann..
CI
2020FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) added to S&P TMI Index
CI
2020FORMA THERAPEUTICS : Appoints Two New Vice Presidents to Lead Key Organizational..
AQ
2020FORMA THERAPEUTICS : Appoints Two New Vice Presidents to Lead Key Organizational..
BU
1  2Next